AdaptHealth (AHCO)
(Real Time Quote from BATS)
$9.58 USD
-0.20 (-2.05%)
Updated Apr 25, 2024 03:08 PM ET
2-Buy of 5 2
A Value A Growth D Momentum A VGM
Cash flow Statements
Fiscal Year End for AdaptHealth Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -674.78 | 73.13 | 158.15 | -58.72 | -12.89 |
Depreciation/Amortization & Depletion | 1,218.80 | 356.41 | 263.43 | 89.64 | 66.00 |
Net Change from Assets/Liabilities | -25.11 | -108.00 | -153.31 | 76.91 | -16.90 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -38.25 | 52.32 | 7.40 | 87.80 | 24.21 |
Net Cash From Operating Activities | 480.67 | 373.87 | 275.68 | 195.63 | 60.42 |
Property & Equipment | -337.46 | -391.42 | -203.31 | -39.76 | -21.33 |
Acquisition/ Disposition of Subsidiaries | -19.69 | -19.02 | -1,620.32 | -769.34 | -63.54 |
Investments | -0.13 | -0.73 | 0.00 | -6.61 | 0.00 |
Other Investing Activities | 0.00 | -0.73 | -1.13 | -8.66 | 0.00 |
Net Cash from Investing Activities | -357.28 | -411.17 | -1,824.75 | -815.70 | -84.87 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -26.66 | 1.62 | 1,391.17 | 697.92 | 105.00 |
Issuance (Repayment) of Debt | -51.77 | -50.17 | 295.57 | 4.74 | 185.66 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -14.10 | -17.50 | -88.00 | -59.51 | -214.51 |
Net Cash from Financing Activities | -92.53 | -66.05 | 1,598.74 | 643.15 | 76.14 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 30.86 | -103.36 | 49.67 | 23.08 | 51.69 |
Cash at Beginning of Period | 46.27 | 149.63 | 99.96 | 76.88 | 25.19 |
Cash at End of Period | 77.13 | 46.27 | 149.63 | 99.96 | 76.88 |
Diluted Net EPS | -5.31 | 0.33 | 0.67 | -1.23 | -0.66 |
Fiscal Year End for AdaptHealth Corp falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -674.78 | -421.21 | 31.72 | 16.68 |
Depreciation/Amortization & Depletion | NA | 1,218.80 | 806.21 | 195.73 | 95.12 |
Net Change from Assets/Liabilities | NA | -25.11 | -37.06 | -11.14 | 38.44 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -38.25 | -22.55 | 10.26 | -9.99 |
Net Cash From Operating Activities | NA | 480.67 | 325.40 | 226.57 | 140.25 |
Property & Equipment | NA | -337.46 | -248.82 | -171.73 | -89.12 |
Acquisition/ Disposition of Subsidiaries | NA | -19.69 | -17.92 | -17.91 | -0.45 |
Investments | NA | -0.13 | -0.13 | -0.13 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | -0.13 | 0.00 |
Net Cash from Investing Activities | NA | -357.28 | -266.86 | -189.76 | -89.57 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -26.66 | -6.66 | -8.20 | -9.22 |
Issuance (Repayment) of Debt | NA | -51.77 | -29.56 | -18.68 | 19.02 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -14.10 | -12.46 | -11.07 | -5.35 |
Net Cash from Financing Activities | NA | -92.53 | -48.67 | -37.95 | 4.45 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 30.86 | 9.87 | -1.15 | 55.13 |
Cash at Beginning of Period | NA | 46.27 | 46.27 | 46.27 | 46.27 |
Cash at End of Period | NA | 77.13 | 56.14 | 45.13 | 101.40 |
Diluted Net EPS | NA | -1.91 | -3.43 | 0.09 | -0.06 |